Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Two Biotech Firms Slash Staff Levels
September 22, 2008
| A version of this story appeared in
Volume 86, Issue 38
Cytokinetics, a South San Francisco-based small-molecule biotech drug company, is reorganizing its research operations to focus on its muscle biology programs and to advance drug candidates in its clinical pipeline. The company will discontinue oncology research activities, reducing its workforce by nearly 30% to 111. Meanwhile, Memory Pharmaceuticals, in Montvale, N.J., is reducing its staff of about 55 employees by more than half to cut costs and focus on clinical development.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter